HEXPOL Valuation

Is HXPL.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of HXPL.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: HXPL.F ($9.32) is trading below our estimate of fair value ($14.87)

Significantly Below Fair Value: HXPL.F is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for HXPL.F?

Key metric: As HXPL.F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for HXPL.F. This is calculated by dividing HXPL.F's market cap by their current earnings.
What is HXPL.F's PE Ratio?
PE Ratio15.1x
EarningsSEK 2.37b
Market CapSEK 35.82b

Price to Earnings Ratio vs Peers

How does HXPL.F's PE Ratio compare to its peers?

The above table shows the PE ratio for HXPL.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average24.2x
IOSP Innospec
20.4x6.9%US$2.9b
SXT Sensient Technologies
36.8x20.2%US$3.3b
KWR Quaker Chemical
22.7x18.3%US$2.8b
MTX Minerals Technologies
16.9x23.1%US$2.6b
HXPL.F HEXPOL
15.1x6.4%US$35.8b

Price-To-Earnings vs Peers: HXPL.F is good value based on its Price-To-Earnings Ratio (15.1x) compared to the peer average (24.2x).


Price to Earnings Ratio vs Industry

How does HXPL.F's PE Ratio compare vs other companies in the US Chemicals Industry?

7 CompaniesPrice / EarningsEstimated GrowthMarket Cap
FFHL Fuwei Films (Holdings)
2.8xn/aUS$27.11m
BSLK Bolt Projects Holdings
0.06xn/aUS$9.57m
BON Bon Natural Life
3xn/aUS$7.35m
GSPI Green Star Products
1.7xn/aUS$1.64m
HXPL.F 15.1xIndustry Avg. 22.7xNo. of Companies8PE01224364860+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: HXPL.F is good value based on its Price-To-Earnings Ratio (15.1x) compared to the US Chemicals industry average (22.7x).


Price to Earnings Ratio vs Fair Ratio

What is HXPL.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HXPL.F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio15.1x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate HXPL.F's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst HXPL.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$9.32
US$11.44
+22.6%
8.7%US$13.20US$10.37n/a6
Nov ’25US$9.92
US$12.02
+21.2%
7.8%US$13.62US$10.70n/a6
Oct ’25US$10.04
US$13.20
+31.5%
7.7%US$14.42US$11.67n/a5
Sep ’25n/a
US$12.96
0%
7.5%US$13.98US$11.32n/a6
Aug ’25US$10.72
US$12.92
+20.5%
5.6%US$13.76US$12.08n/a6
Jul ’25US$10.85
US$13.41
+23.5%
5.5%US$14.31US$12.31n/a6
Jun ’25n/a
US$13.09
0%
5.8%US$14.01US$12.04n/a6
May ’25US$11.40
US$12.51
+9.7%
10.5%US$13.73US$9.88n/a6
Apr ’25US$12.26
US$12.65
+3.2%
9.7%US$14.07US$10.34n/a6
Mar ’25US$11.71
US$12.65
+8.0%
9.7%US$14.07US$10.34n/a6
Feb ’25US$11.45
US$12.65
+10.5%
9.7%US$14.07US$10.34n/a6
Jan ’25US$12.06
US$12.01
-0.4%
6.6%US$12.80US$10.63n/a5
Dec ’24US$9.85
US$11.43
+16.1%
6.7%US$12.32US$10.05n/a5
Nov ’24US$8.56
US$10.83
+26.6%
6.7%US$11.67US$9.52US$9.925
Oct ’24US$8.68
US$11.79
+35.8%
7.8%US$12.96US$10.27US$10.045
Sep ’24US$9.87
US$11.79
+19.5%
7.8%US$12.96US$10.27n/a5
Aug ’24US$10.88
US$11.79
+8.4%
7.8%US$12.96US$10.27US$10.725
Jul ’24US$10.10
US$11.56
+14.4%
8.7%US$13.10US$10.07US$10.855
Jun ’24US$9.92
US$11.65
+17.5%
8.7%US$13.20US$10.16n/a5
May ’24US$11.59
US$11.90
+2.7%
9.3%US$13.73US$10.56US$11.405
Apr ’24US$12.46
US$11.88
-4.6%
8.5%US$13.48US$10.59US$12.265
Mar ’24US$11.05
US$11.27
+2.0%
3.5%US$11.58US$10.61US$11.714
Feb ’24US$10.86
US$11.32
+4.2%
3.5%US$11.64US$10.67US$11.454
Jan ’24US$10.75
US$11.93
+10.9%
9.7%US$13.63US$10.56US$12.064
Dec ’23US$10.61
US$10.93
+3.0%
9.8%US$12.69US$9.83US$9.854
Nov ’23US$10.00
US$11.12
+11.2%
10.3%US$12.97US$9.86US$8.564

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies